Pub Date : 2026-03-03DOI: 10.1016/s2214-109x(25)00496-6
Francesca Celletti, Claire Chaumont, Jørgen Torgerstuen Johnsen, Francesco Branca, Anna Wright, Jennifer Manne-Goehler, Melanie Bertram, Rupasree Srikumar, Pavel Ursu, Luz Maria De-Regil
{"title":"From endorsement of the WHO Acceleration Plan to Stop Obesity to national implementation: country progress on health system preparedness to scale up a comprehensive obesity chronic care programme","authors":"Francesca Celletti, Claire Chaumont, Jørgen Torgerstuen Johnsen, Francesco Branca, Anna Wright, Jennifer Manne-Goehler, Melanie Bertram, Rupasree Srikumar, Pavel Ursu, Luz Maria De-Regil","doi":"10.1016/s2214-109x(25)00496-6","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00496-6","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"29 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147360549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-03DOI: 10.1016/s2214-109x(25)00536-4
Bingqing Guo, Karen Ann Grépin
{"title":"Measurement matters: implications of the newly revised Sustainable Development Goal 3.8.2 financial protection indicator for global monitoring","authors":"Bingqing Guo, Karen Ann Grépin","doi":"10.1016/s2214-109x(25)00536-4","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00536-4","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"3 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147360550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-07DOI: 10.1016/S2214-109X(25)00431-0
Nyashadzaishe Mafirakureva, Anna Cartledge, Isobella Bradshaw, Adrie Bekker, Nicole Salazar-Austin, Sue-Ann Meehan, Landon Myer, Jasantha Odayar, Molebogeng X Rangaka, Peter J Dodd
Background: Despite known maternal, perinatal, and infant health risks of tuberculosis during pregnancy, global estimates of incidence remain scarce. Existing estimates are outdated, and do not include the postpartum period, HIV co-infection, age, or specific changes in risk, limiting our understanding of the true scale of disease in this understudied population.
Methods: In this rapid review and modelling analysis, we estimated the global tuberculosis incidence in pregnant and postpartum women using a population-based modelling approach. We searched MEDLINE and EMBASE, with no date or language limits, and included studies reporting tuberculosis incidence in pregnancy or postpartum with suitable comparison groups; we also used Feb 6, 2025, interim data from the ongoing ORCHID cohort. We combined WHO age and sex-stratified tuberculosis incidence data with country-specific population and fertility data to estimate baseline tuberculosis incidence, and applied systematic review-based risk ratios to account for elevated increased risk during pregnancy and postpartum. Uncertainty in all inputs was propagated using standard error propagation formulae and summarised as mean tuberculosis incidence rates and mean incidence rate ratios (IRRs), each reported with 95% quantile-based uncertainty intervals (UIs).
Findings: We identified 37 studies published between 1996 and 2020, of which three were of sufficient quality to provide data for HIV-negative women. One additional study (ORCHID; Odayar et al, unpublished) provided data for women living with HIV. Compared with non-pregnant women without HIV, tuberculosis IRRs were 1·34 (95% CI 1·17-1·54) during pregnancy and 1·91 (1·53-2·39) during postpartum among HIV-negative women. For women living with HIV, IRRs were 5·73 (95% CI 2·64-10·94) during pregnancy and 3·58 (0·85-9·63) postpartum. We estimated 239 500 pregnant women (95% UI 216 300-262 800) and 97 600 postpartum women (90 100-105 200) developed tuberculosis disease globally in 2023, with HIV contributing to 21·3% (19·8-22·8) and 10·6% (9·9-11·3) of cases, respectively. The WHO African region had the highest incidence (110 600 [95% UI 96 700-124 500] in pregnant women and 40 900 [36 300-45 400] in postpartum women), followed by the South-East Asia region (79 900 [64 100-95 700] in pregnant women and 35 900 [30 800-41 100] in postpartum women).
Interpretation: Pregnant and postpartum women face substantial tuberculosis risk, yet remain under-represented in global estimates. Our findings underscore the need for improved surveillance and targeted interventions to reduce tuberculosis incidence in this group.
{"title":"Global estimates of tuberculosis incidence during pregnancy and postpartum: a rapid review and modelling analysis.","authors":"Nyashadzaishe Mafirakureva, Anna Cartledge, Isobella Bradshaw, Adrie Bekker, Nicole Salazar-Austin, Sue-Ann Meehan, Landon Myer, Jasantha Odayar, Molebogeng X Rangaka, Peter J Dodd","doi":"10.1016/S2214-109X(25)00431-0","DOIUrl":"10.1016/S2214-109X(25)00431-0","url":null,"abstract":"<p><strong>Background: </strong>Despite known maternal, perinatal, and infant health risks of tuberculosis during pregnancy, global estimates of incidence remain scarce. Existing estimates are outdated, and do not include the postpartum period, HIV co-infection, age, or specific changes in risk, limiting our understanding of the true scale of disease in this understudied population.</p><p><strong>Methods: </strong>In this rapid review and modelling analysis, we estimated the global tuberculosis incidence in pregnant and postpartum women using a population-based modelling approach. We searched MEDLINE and EMBASE, with no date or language limits, and included studies reporting tuberculosis incidence in pregnancy or postpartum with suitable comparison groups; we also used Feb 6, 2025, interim data from the ongoing ORCHID cohort. We combined WHO age and sex-stratified tuberculosis incidence data with country-specific population and fertility data to estimate baseline tuberculosis incidence, and applied systematic review-based risk ratios to account for elevated increased risk during pregnancy and postpartum. Uncertainty in all inputs was propagated using standard error propagation formulae and summarised as mean tuberculosis incidence rates and mean incidence rate ratios (IRRs), each reported with 95% quantile-based uncertainty intervals (UIs).</p><p><strong>Findings: </strong>We identified 37 studies published between 1996 and 2020, of which three were of sufficient quality to provide data for HIV-negative women. One additional study (ORCHID; Odayar et al, unpublished) provided data for women living with HIV. Compared with non-pregnant women without HIV, tuberculosis IRRs were 1·34 (95% CI 1·17-1·54) during pregnancy and 1·91 (1·53-2·39) during postpartum among HIV-negative women. For women living with HIV, IRRs were 5·73 (95% CI 2·64-10·94) during pregnancy and 3·58 (0·85-9·63) postpartum. We estimated 239 500 pregnant women (95% UI 216 300-262 800) and 97 600 postpartum women (90 100-105 200) developed tuberculosis disease globally in 2023, with HIV contributing to 21·3% (19·8-22·8) and 10·6% (9·9-11·3) of cases, respectively. The WHO African region had the highest incidence (110 600 [95% UI 96 700-124 500] in pregnant women and 40 900 [36 300-45 400] in postpartum women), followed by the South-East Asia region (79 900 [64 100-95 700] in pregnant women and 35 900 [30 800-41 100] in postpartum women).</p><p><strong>Interpretation: </strong>Pregnant and postpartum women face substantial tuberculosis risk, yet remain under-represented in global estimates. Our findings underscore the need for improved surveillance and targeted interventions to reduce tuberculosis incidence in this group.</p><p><strong>Funding: </strong>UK Medical Research Council.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e337-e346"},"PeriodicalIF":19.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-19DOI: 10.1016/s2214-109x(26)00016-1
Nelson Aghogho Evaborhene
{"title":"Protecting global health in the era of the America First Strategy","authors":"Nelson Aghogho Evaborhene","doi":"10.1016/s2214-109x(26)00016-1","DOIUrl":"https://doi.org/10.1016/s2214-109x(26)00016-1","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"55 38 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146777348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(25)00470-x
Kexin Xie BSc, Rachel Otuko MPH, Achla Marathe PhD, Almudena Sanz Gutierrez MSc, Mercy Kariuki MSc, Leah Musyoka BSc, Esther Yaa IT Tech, Jamal Mbarak IT Tech, Isaiah Omondi MSc, Lydia Kasiwa MSc, Regina Rabinovich MD, Marta Maia PhD, Carlos Chaccour PhD, Xinwei Deng PhD, Cassidy Rist DVM
Malaria remains a major health burden in sub-Saharan Africa, where traditional vector control methods are hindered by insecticide resistance and evolving mosquito behaviour causing residual transmission. In the BOHEMIA cluster-randomised trial in Kenya, ivermectin mass drug administration (iMDA), delivered once a month for 3 months with approximately 64% population coverage, was shown to reduce malaria incidence by 26%. We aimed to assess the cost-effectiveness of iMDA as a supplementary vector control tool using data from the BOHEMIA trial in Kenya.
{"title":"Cost and cost-effectiveness of ivermectin mass drug administration for malaria control in Kwale county, Kenya: a modelling analysis of a cluster-randomised trial","authors":"Kexin Xie BSc, Rachel Otuko MPH, Achla Marathe PhD, Almudena Sanz Gutierrez MSc, Mercy Kariuki MSc, Leah Musyoka BSc, Esther Yaa IT Tech, Jamal Mbarak IT Tech, Isaiah Omondi MSc, Lydia Kasiwa MSc, Regina Rabinovich MD, Marta Maia PhD, Carlos Chaccour PhD, Xinwei Deng PhD, Cassidy Rist DVM","doi":"10.1016/s2214-109x(25)00470-x","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00470-x","url":null,"abstract":"Malaria remains a major health burden in sub-Saharan Africa, where traditional vector control methods are hindered by insecticide resistance and evolving mosquito behaviour causing residual transmission. In the BOHEMIA cluster-randomised trial in Kenya, ivermectin mass drug administration (iMDA), delivered once a month for 3 months with approximately 64% population coverage, was shown to reduce malaria incidence by 26%. We aimed to assess the cost-effectiveness of iMDA as a supplementary vector control tool using data from the BOHEMIA trial in Kenya.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"47 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(26)00030-6
The Lancet Global Health
{"title":"Safeguarding women and girls in the age of AI","authors":"The Lancet Global Health","doi":"10.1016/s2214-109x(26)00030-6","DOIUrl":"https://doi.org/10.1016/s2214-109x(26)00030-6","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"123 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(25)00500-5
Ha V Tran, Ha TT Nong
{"title":"Comment on a three-arm pragmatic trial on tobacco cessation interventions for people living with HIV in Viet Nam","authors":"Ha V Tran, Ha TT Nong","doi":"10.1016/s2214-109x(25)00500-5","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00500-5","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"4 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(26)00014-8
{"title":"Correction to Lancet Glob Health 2026; 14: e233–41","authors":"","doi":"10.1016/s2214-109x(26)00014-8","DOIUrl":"https://doi.org/10.1016/s2214-109x(26)00014-8","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"59 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(25)00473-5
Peige Song PhD, Denan Jiang MPH, Jiali Zhou PhD, Prof Yajie Zhu PhD, Rosliza Abdul Manaf PhD, Prof Danladi Adamu Bojude PhD, Marie Laurette Agbre-Yace MD MPH, Sajjad Ali MBBS, Omolade Allen PhD, Anayochukwu Edward Anyasodor PhD, Zeus Aranda MSc, Awsan Bahattab PhD, Prof Adams Bodomo PhD, Florencia Borrescio-Higa PhD, Marie Buchtova PhD, Nataša Buljan MD, Vaishali Deshmukh PhD, Prof Lina Díaz-Castro MD PhD, Sohaila Cheema MBBS MPH, Winifred Ekezie PhD, Kurubaran Ganasegeran MSc, Balasankar Ganesan PhD, Anton Glasnović PhD, Christopher J Graham MPH, Mila Nu Nu Htay PhD, Chinonso Igwesi-Chidobe PhD, Prof Per Ole Iversen MD, Prof Mohammad Mainul Islam PhD, Prof Abdulkarim Jafar Karim PhD, Brane Kalpič PhD, Oluchi Kanma-Okafor MPH, Prof Giuseppe Lanza MD PhD, Prof Saturnino Luz PhD, Wiriya Mahikul PhD, Prof Dunja Mladenić PhD, Anthony Muchai Manyara PhD, Bala Munipalli MD, Nellie Myburgh PhD, Zhi Xiang Ng PhD, Georgios Nikolopoulos PhD, Chulwoo Park DrPH, Jay J Park MBChB, Prince Peprah PhD, Klara Rudan MD, Syed Ahmar Shah PhD, Ting Shi PhD, Gregor š tiglic PhD, Prof Rosnah Sutan PhD, Prof Athanasios Tsanas PhD, Holly Tibble PhD, Abdul Tawab Khpalwak MD, Prof Mark Tomlinson PhD, Prof Sandro Vento MD, Josipa Vlasac Glasnović MD, Prof Liang Wang PhD, Jingyi Xu SJD, Jianrong Zhang MD, Prof Yanfeng Zhang MMed, Eamon Sheikh BSc, Obianuju B Ozoh MBBS MSc, Apostolos Tsiachristas PhD, Davies Adeloye MD PhD, Steven Kerr PhD, Mili Sanwalka MBA, Prof Stjepan Orešković PhD, Prof Aziz Sheikh MD, Prof Igor Rudan PhD
Applications of data science and artificial intelligence (AI) in global health are expanding, yet research remains fragmented and often misaligned with the needs of low-income and middle-income countries (LMICs). To address this misalignment, we conducted a global research priority-setting exercise using the Child Health and Nutrition Research Initiative (CHNRI) method. 155 research ideas were scored by 51 experts based on feasibility, potential impact on disease burden, paradigm shift potential, implementation potential, and equity. Top-ranked priorities focused on epidemic preparedness, including AI-based outbreak prediction, improved diagnostics for infectious diseases, and early-warning systems. Other highly ranked topics included AI-assisted resource allocation, telemedicine, culturally adapted mobile health services, and chronic disease management tools. Experts from LMICs prioritised infectious disease control and diagnostic equity, whereas experts from high-income countries emphasised infrastructure and climate-related analytics. The resulting agenda provides a roadmap for aligning AI and data science research with global health priorities, particularly in LMICs.
{"title":"Research priorities for data science and artificial intelligence in global health: an international consensus exercise","authors":"Peige Song PhD, Denan Jiang MPH, Jiali Zhou PhD, Prof Yajie Zhu PhD, Rosliza Abdul Manaf PhD, Prof Danladi Adamu Bojude PhD, Marie Laurette Agbre-Yace MD MPH, Sajjad Ali MBBS, Omolade Allen PhD, Anayochukwu Edward Anyasodor PhD, Zeus Aranda MSc, Awsan Bahattab PhD, Prof Adams Bodomo PhD, Florencia Borrescio-Higa PhD, Marie Buchtova PhD, Nataša Buljan MD, Vaishali Deshmukh PhD, Prof Lina Díaz-Castro MD PhD, Sohaila Cheema MBBS MPH, Winifred Ekezie PhD, Kurubaran Ganasegeran MSc, Balasankar Ganesan PhD, Anton Glasnović PhD, Christopher J Graham MPH, Mila Nu Nu Htay PhD, Chinonso Igwesi-Chidobe PhD, Prof Per Ole Iversen MD, Prof Mohammad Mainul Islam PhD, Prof Abdulkarim Jafar Karim PhD, Brane Kalpič PhD, Oluchi Kanma-Okafor MPH, Prof Giuseppe Lanza MD PhD, Prof Saturnino Luz PhD, Wiriya Mahikul PhD, Prof Dunja Mladenić PhD, Anthony Muchai Manyara PhD, Bala Munipalli MD, Nellie Myburgh PhD, Zhi Xiang Ng PhD, Georgios Nikolopoulos PhD, Chulwoo Park DrPH, Jay J Park MBChB, Prince Peprah PhD, Klara Rudan MD, Syed Ahmar Shah PhD, Ting Shi PhD, Gregor š tiglic PhD, Prof Rosnah Sutan PhD, Prof Athanasios Tsanas PhD, Holly Tibble PhD, Abdul Tawab Khpalwak MD, Prof Mark Tomlinson PhD, Prof Sandro Vento MD, Josipa Vlasac Glasnović MD, Prof Liang Wang PhD, Jingyi Xu SJD, Jianrong Zhang MD, Prof Yanfeng Zhang MMed, Eamon Sheikh BSc, Obianuju B Ozoh MBBS MSc, Apostolos Tsiachristas PhD, Davies Adeloye MD PhD, Steven Kerr PhD, Mili Sanwalka MBA, Prof Stjepan Orešković PhD, Prof Aziz Sheikh MD, Prof Igor Rudan PhD","doi":"10.1016/s2214-109x(25)00473-5","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00473-5","url":null,"abstract":"Applications of data science and artificial intelligence (AI) in global health are expanding, yet research remains fragmented and often misaligned with the needs of low-income and middle-income countries (LMICs). To address this misalignment, we conducted a global research priority-setting exercise using the Child Health and Nutrition Research Initiative (CHNRI) method. 155 research ideas were scored by 51 experts based on feasibility, potential impact on disease burden, paradigm shift potential, implementation potential, and equity. Top-ranked priorities focused on epidemic preparedness, including AI-based outbreak prediction, improved diagnostics for infectious diseases, and early-warning systems. Other highly ranked topics included AI-assisted resource allocation, telemedicine, culturally adapted mobile health services, and chronic disease management tools. Experts from LMICs prioritised infectious disease control and diagnostic equity, whereas experts from high-income countries emphasised infrastructure and climate-related analytics. The resulting agenda provides a roadmap for aligning AI and data science research with global health priorities, particularly in LMICs.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"18 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146209070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-16DOI: 10.1016/s2214-109x(25)00490-5
Anthony Muchai Manyara PhD, Tadios Manyanga MSc, Momodou Jallow BSc, Etheldreda I Yoliswa Madela MD, Hannah Wilson PhD, Anya Burton PhD, Farhanah Paruk PhD, Chris Grundy MSc, Lucy Gates PhD, Isatou Drammeh PhD, Prof Bilkish Cassim MD, Prof Rashida A Ferrand PhD, Prof Kate A Ward PhD, Prof Celia L Gregson PhD
Despite rising longevity across Africa, the epidemiology of intrinsic capacity (combination of mental and physical capacities) impairments (ICIs) is understudied. We aimed to determine the prevalence of ICIs and associated sociodemographic and lifestyle factors, pain, functional limitations, and health-related quality of life (HRQoL) across three African countries.
{"title":"Prevalence and outcomes of intrinsic capacity impairments assessed using the WHO Integrated Care for Older People (ICOPE) framework in The Gambia, South Africa, and Zimbabwe: a cross-sectional study","authors":"Anthony Muchai Manyara PhD, Tadios Manyanga MSc, Momodou Jallow BSc, Etheldreda I Yoliswa Madela MD, Hannah Wilson PhD, Anya Burton PhD, Farhanah Paruk PhD, Chris Grundy MSc, Lucy Gates PhD, Isatou Drammeh PhD, Prof Bilkish Cassim MD, Prof Rashida A Ferrand PhD, Prof Kate A Ward PhD, Prof Celia L Gregson PhD","doi":"10.1016/s2214-109x(25)00490-5","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00490-5","url":null,"abstract":"Despite rising longevity across Africa, the epidemiology of intrinsic capacity (combination of mental and physical capacities) impairments (ICIs) is understudied. We aimed to determine the prevalence of ICIs and associated sociodemographic and lifestyle factors, pain, functional limitations, and health-related quality of life (HRQoL) across three African countries.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"11 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146208909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号